Annual CFI
$8.56 M
-$51.93 M-85.84%
December 1, 2024
Summary
- As of March 13, 2025, UBX annual cash flow from investing activities is $8.56 million, with the most recent change of -$51.93 million (-85.84%) on December 1, 2024.
- During the last 3 years, UBX annual CFI has fallen by -$30.75 million (-78.21%).
- UBX annual CFI is now -87.40% below its all-time high of $67.95 million, reached on December 31, 2019.
Performance
UBX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$4.58 M
-$1.93 M-29.64%
December 1, 2024
Summary
- As of March 13, 2025, UBX quarterly cash flow from investing activities is $4.58 million, with the most recent change of -$1.93 million (-29.64%) on December 1, 2024.
- Over the past year, UBX quarterly CFI has dropped by -$1.93 million (-29.64%).
- UBX quarterly CFI is now -88.57% below its all-time high of $40.06 million, reached on March 31, 2019.
Performance
UBX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$8.56 M
-$10.54 M-55.16%
December 1, 2024
Summary
- As of March 13, 2025, UBX TTM cash flow from investing activities is $8.56 million, with the most recent change of -$10.54 million (-55.16%) on December 1, 2024.
- Over the past year, UBX TTM CFI has dropped by -$10.54 million (-55.16%).
- UBX TTM CFI is now -88.01% below its all-time high of $71.44 million, reached on September 30, 2019.
Performance
UBX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
UBX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -85.8% | -29.6% | -55.2% |
| 3 y3 years | -78.2% | +2496.9% | +134.9% |
| 5 y5 years | -87.4% | +2496.9% | +134.9% |
UBX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -85.8% | +134.9% | -78.5% | +112.6% | -85.8% | +134.9% |
| 5 y | 5-year | -87.4% | +134.9% | -78.5% | +112.6% | -87.4% | +134.9% |
| alltime | all time | -87.4% | +109.9% | -88.6% | +104.9% | -88.0% | +108.0% |
Unity Biotechnology Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $8.56 M(-85.8%) | $4.58 M(-29.6%) | $8.56 M(-55.2%) |
| Sep 2024 | - | $6.51 M(+39.3%) | $19.10 M(-28.8%) |
| Jun 2024 | - | $4.67 M(-165.0%) | $26.84 M(-16.2%) |
| Mar 2024 | - | -$7.19 M(-147.6%) | $32.03 M(-47.1%) |
| Dec 2023 | $60.49 M(-346.5%) | $15.11 M(+6.1%) | $60.49 M(+33.9%) |
| Sep 2023 | - | $14.25 M(+44.6%) | $45.19 M(-954.4%) |
| Jun 2023 | - | $9.85 M(-53.7%) | -$5.29 M(-307.4%) |
| Mar 2023 | - | $21.28 M(<-9900.0%) | $2.55 M(-110.4%) |
| Dec 2022 | -$24.55 M(-162.4%) | -$191.00 K(-99.5%) | -$24.55 M(+60.7%) |
| Sep 2022 | - | -$36.23 M(-304.8%) | -$15.28 M(-140.1%) |
| Jun 2022 | - | $17.69 M(-404.2%) | $38.11 M(+96.1%) |
| Mar 2022 | - | -$5.82 M(-164.1%) | $19.43 M(-50.6%) |
| Dec 2021 | $39.31 M(-854.9%) | $9.08 M(-47.1%) | $39.31 M(+151.0%) |
| Sep 2021 | - | $17.15 M(-1852.0%) | $15.66 M(-293.3%) |
| Jun 2021 | - | -$979.00 K(-107.0%) | -$8.10 M(-256.1%) |
| Mar 2021 | - | $14.06 M(-196.5%) | $5.19 M(-199.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$5.21 M(-107.7%) | -$14.57 M(+120.6%) | -$5.21 M(-206.4%) |
| Sep 2020 | - | -$6.61 M(-153.7%) | $4.89 M(-86.6%) |
| Jun 2020 | - | $12.31 M(+235.8%) | $36.58 M(+15.9%) |
| Mar 2020 | - | $3.67 M(-182.0%) | $31.56 M(-53.6%) |
| Dec 2019 | $67.95 M(-194.1%) | -$4.47 M(-117.8%) | $67.95 M(-4.9%) |
| Sep 2019 | - | $25.08 M(+244.3%) | $71.44 M(+29.9%) |
| Jun 2019 | - | $7.28 M(-81.8%) | $54.98 M(-221.9%) |
| Mar 2019 | - | $40.06 M(-4150.6%) | -$45.09 M(-37.5%) |
| Dec 2018 | -$72.21 M(-16.3%) | -$989.00 K(-111.5%) | -$72.21 M(+15.9%) |
| Sep 2018 | - | $8.63 M(-109.3%) | -$62.27 M(+4.4%) |
| Jun 2018 | - | -$92.79 M(-816.7%) | -$59.63 M(+330.5%) |
| Mar 2018 | - | $12.95 M(+44.8%) | -$13.85 M(-84.0%) |
| Dec 2017 | -$86.31 M(+3045.2%) | $8.94 M(-20.7%) | -$86.31 M(-9.4%) |
| Sep 2017 | - | $11.27 M(-124.0%) | -$95.25 M(-10.6%) |
| Jun 2017 | - | -$47.01 M(-21.0%) | -$106.52 M(+79.0%) |
| Mar 2017 | - | -$59.51 M | -$59.51 M |
| Dec 2016 | -$2.74 M | - | - |
FAQ
- What is Unity Biotechnology annual cash flow from investing activities?
- What is the all time high annual CFI for Unity Biotechnology?
- What is Unity Biotechnology annual CFI year-on-year change?
- What is Unity Biotechnology quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Unity Biotechnology?
- What is Unity Biotechnology quarterly CFI year-on-year change?
- What is Unity Biotechnology TTM cash flow from investing activities?
- What is the all time high TTM CFI for Unity Biotechnology?
- What is Unity Biotechnology TTM CFI year-on-year change?
What is Unity Biotechnology annual cash flow from investing activities?
The current annual CFI of UBX is $8.56 M
What is the all time high annual CFI for Unity Biotechnology?
Unity Biotechnology all-time high annual cash flow from investing activities is $67.95 M
What is Unity Biotechnology annual CFI year-on-year change?
Over the past year, UBX annual cash flow from investing activities has changed by -$51.93 M (-85.84%)
What is Unity Biotechnology quarterly cash flow from investing activities?
The current quarterly CFI of UBX is $4.58 M
What is the all time high quarterly CFI for Unity Biotechnology?
Unity Biotechnology all-time high quarterly cash flow from investing activities is $40.06 M
What is Unity Biotechnology quarterly CFI year-on-year change?
Over the past year, UBX quarterly cash flow from investing activities has changed by -$1.93 M (-29.64%)
What is Unity Biotechnology TTM cash flow from investing activities?
The current TTM CFI of UBX is $8.56 M
What is the all time high TTM CFI for Unity Biotechnology?
Unity Biotechnology all-time high TTM cash flow from investing activities is $71.44 M
What is Unity Biotechnology TTM CFI year-on-year change?
Over the past year, UBX TTM cash flow from investing activities has changed by -$10.54 M (-55.16%)